On July 28, Medtronic PLC rose 3.57% in regular trading, trading at $88.518/share, with turnover of $347 million. The stock rallied alongside a broad-based gain in the Health Care Equipment sector, further supported by approaching earnings expectations and recent strategic acquisitions.
On the sector front, Health Care Equipment stocks posted strong gains across the board, with Abbott Laboratories up 4.06%, Stryker up 3.99%, Intuitive Surgical up 3.46%, and Boston Scientific up 2.81%. Medtronic tracked the sector-wide rally.
On the news front, the company previously announced it will release FY2027 Q1 earnings on August 18 before market open, with market consensus expecting quarterly revenue of $8.2 billion to $8.5 billion, representing approximately 4%-6% year-over-year growth. Additionally, Medtronic recently completed the $650 million acquisition of SPR Therapeutics and the $550 million acquisition of Scientia Vascular, strengthening its pain management and neurovascular business lines. The accelerating product cycle combined with the approaching earnings window contributed to positive market sentiment.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments